Cited by 1,413Atherosclerosis and Cardiovascular DiseasesCholesterol and Lipid MetabolismNitric Oxide and Endothelin Effects

The Response-to-Retention Hypothesis of Early Atherogenesis

Open access
Williams, Kevin Jon, Tabas, Ira·1995·Arteriosclerosis, Thrombosis, and Vascular Biology

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.atv.15.5.551

Cites

240 of 240 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Retention of lipoproteins in the arterial extracellular matrix is a critical step in atherogenesis in which lipoproteins with higher affinity for arterial proteoglycans are more atherogenic.

    “The retention of lipoproteins in the arterial extracellular matrix is a critical step in atherogenesis in which lipoproteins with higher affinity for arterial proteoglycans are more atherogenic (55, 56).”
  • The ECM has a central role in initiation of atherosclerosis, primarily through the interaction between the negatively charged side chains of proteoglycans with positively charged apolipoproteins, which leads to the retention of plasma-derived lipoproteins.

    “The ECM has a central role in initiation of atherosclerosis, primarily through the interaction between the negatively charged side chains of proteoglycans (particularly chondroitin sulphate of biglycan and versican and heparin sulphate of perlecan 110 ) with positively charged apolipoproteins (especially apolipoprotein B) , which leads to the retention of plasma-derived lipoproteins 101,111 - as”

    From Vascular smooth muscle cells in atherosclerosis (2019) · cites this paper as [113]

  • Interaction of apoB-containing lipoproteins with intimal extracellular proteoglycans inhibits their movement, producing higher subendothelial concentrations in the intima than in other tissues.

    “the interaction of apoB-containing lipoproteins (the non-HDL lipoproteins) with intimal extracellular proteoglycans (referred to as retention)1,43,44 inhibits the movement of the lipoproteins, thereby resulting in much higher subendothelial concentrations of these lipoproteins in the intima than in any other tissue45.”
  • Atherosclerosis is a low-grade chronic inflammatory disease of the arterial wall triggered by subendothelial retention of apolipoprotein B-containing lipoproteins.

    “Atherosclerosis is a disease characterized by low-grade, chronic inflammation of the arterial wall and is triggered by the subendothelial retention of plasma-derived, apolipoprotein B (apoB)-containing lipoproteins in the affected inner layer of the arterial wall, the intima1–3.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 8

  1. [5]Wissler RW. Morphological characteristics of the developing atherosclerotic plaque: animal studies and studies of lesions from young people. Atheroscler Rev. 1991;23:91–103. [Google Scholar]
  2. [28]Anitschkow N, Chalatow S. Über experimentelle Cholesterinsteatose und ihre Bedeutung für die Entstehung einiger pathologischer Prozesse. Zentralbl Allg Pathol. 1913;24:1–9. [Google Scholar]
  3. [103]Lund G, Beisiegel U, Seeber N, Nikutta P, Hamm CW. Abstracts Submitted to the Council on Arteriosclerosis for the 66th Scientific Sessions of the American Heart Association. Dallas, Tex: American Heart Association Inc; 1993. Effect of probucol on progression/regression of coronary artery disease; p. 124. [Google Scholar]
  4. [122]Williams KJ, Fless GM, Petrie K, Snyder ML, Brocia RW, Swenson TL. Lipoprotein lipase enhances cellular catabolism of lipoprotein(a) Circulation. 1991;84(suppl II):II-566. [Google Scholar]
  5. [130]Schissel SL, Williams KJ, Tabas I. Sphingomyelinase (SMase)-induced LDL aggregation: mechanism and relevance. Circulation. 1994;90(pt 2):I-403. [Google Scholar]
  6. [139]Williams KJ, Swenson TL, Brocia RW, Rothman VL, Tuszynski GP, Fisher EA. Involvement of the syndecan family of heparan sulfate proteoglycans (HSPGs) in cellular uptake of complexes of lipoprotein lipase (LpL) with lipoproteins. Circulation. 1993;88(suppl I):I-365. [Google Scholar]
  7. [210]Shimano H, Yamada N, Ohsuga J, Shimada M, Yazaki Y. Anti-atherogenic effect of apolipoprotein E is mediated through enhanced cholesterol efflux in transgenic mice. Circulation. 1993;88(suppl I):I-421. [Google Scholar]
  8. [229]Hurt-Camejo E, Camejo G, Rosengren B, Bondjers G. LDL binding to matrix proteoglycans from smooth muscle cells is modulated by cell secreted and martix bound phospholipase A2. Circulation. 1994;90(pt 2):I-403. [Google Scholar]

Cited by

Sorted by citations

Authors
Williams, K. J., & Tabas, I.
Affiliations
Thomas Jefferson University (US)
Venue
Arteriosclerosis, Thrombosis, and Vascular Biology
Published
1995-05
Volume
15
Issue
5
Pages
551-561
ISSN
  • 1079-5642 (ISSN-L)
  • 1524-4636
OpenAlex
W1968171440
Cited by
1,413
References
240
Citations by year
2026: 27 · 2025: 34 · 2024: 37 · 2023: 40 · 2022: 42 · 2021: 39 · 2020: 55 · 2019: 47 · 2018: 42 · 2017: 41 · 2016: 59 · 2015: 73 · 2014: 60 · 2013: 56 · 2012: 60
FWCI
12.35
Type
journal article
Language
en
Open access
Locations
  • Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • American Heart Association
  • National Institutes of Health (5p50hl021006-17, 5r01hl039703-08)
  • Genentech
  • National Heart, Lung, and Blood Institute (HL 38956, HL-39703, HL 21006, R01HL038956)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
  • Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
  • Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
Keywords
atherosclerosis initiation, plaque retention, endothelial dysfunction
MeSH terms
Animals, Arteries, Arteriosclerosis, Humans, Lipoproteins, LDL, Models, Biological, Proteoglycans

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review